Titlebook: Current Directions in Radiopharmaceutical Research and Development; Stephen J. Mather Book 1996 Kluwer Academic Publishers 1996 CNS.cell.c

ergonomics

书目名称Current Directions in Radiopharmaceutical Research and Development影响因子(影响力)




书目名称Current Directions in Radiopharmaceutical Research and Development影响因子(影响力)学科排名




书目名称Current Directions in Radiopharmaceutical Research and Development网络公开度




书目名称Current Directions in Radiopharmaceutical Research and Development网络公开度学科排名




书目名称Current Directions in Radiopharmaceutical Research and Development被引频次




书目名称Current Directions in Radiopharmaceutical Research and Development被引频次学科排名




书目名称Current Directions in Radiopharmaceutical Research and Development年度引用




书目名称Current Directions in Radiopharmaceutical Research and Development年度引用学科排名




书目名称Current Directions in Radiopharmaceutical Research and Development读者反馈




书目名称Current Directions in Radiopharmaceutical Research and Development读者反馈学科排名

Lucubrate

BOAST

The Development of Radiopharmaceuticals for Imaging CNS Receptors,ciation constant; or K., inhibition constant). When a ligand is bound to a receptor (R) located in the cell membrane, the ligand-receptor complex triggers responses of secondary messengers (i.e., induce protein kinase activity). There is a large number of CNS receptors responsible for different types of neuronal function.

感激小女

Computer Modelling of Metal-Based Radiopharmaceuticals,raphics. Most of these packages also make possible wave-mechanical calculations, which are useful in predicting properties such as electronic spectra, and magnetic properties. A selection of computer molecular modelling packages is listed below:

富足女人

标准

标准

Maria Lodovica Gullino,Laura Vivanimed by the “zippering” of two complementary single-stranded oligonucleotides by Watson-Crick base pairing can be termed hybridization [1]. It is this property of hybridization, unique to RNA and DNA (if artificial oligomers are excluded), which is likely to render in the near future radiolabeled oligonucleotides useful as radiopharmaceuticals.

缓和

Bifunctional Chelators for Technetium-99m,ociated with technetium is the fact that it cannot simply replace a hydrogen atom as it is the case with halogens like .I and .F, nor can be a substitute for one of the other common atoms in biologically interesting compounds, i.e. carbon, nitrogen or oxygen.

Anguish

Therapeutic Radionuclides: Making the Right Choice,chniques that have recently emerged, (e.g., tumor therapy with radiolabeled monoclonal antibodies, treatment of metastatic bone pain, etc.) appear to have provided a substantial impetus to research on production of new therapeutic radionuclides (4–7).

indices

Labelling Oligonucleotides with Imagable Radionuclides,med by the “zippering” of two complementary single-stranded oligonucleotides by Watson-Crick base pairing can be termed hybridization [1]. It is this property of hybridization, unique to RNA and DNA (if artificial oligomers are excluded), which is likely to render in the near future radiolabeled oligonucleotides useful as radiopharmaceuticals.